Common cholesterol drug tested for rare childhood skin condition
NCT ID NCT05488067
Summary
This study tested whether the cholesterol-lowering drug atorvastatin is safe and effective for treating skin growths called xanthomas in children with Alagille Syndrome. It involved 15 children and teenagers, who took the drug for up to 6 months while doctors monitored changes in their skin growths and cholesterol levels. The goal was to see if this widely available pill could offer a simpler, less invasive treatment option for these often-disfiguring growths.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALAGILLE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
Conditions
Explore the condition pages connected to this study.